We could not find any results for:
Make sure your spelling is correct or try broadening your search.
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is als... YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China. Show more
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition PR Newswire GAITHERSBURG, Md., July 5, 2024 GAITHERSBURG, Md., July 5, 2024...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0549 | -10.261682243 | 0.535 | 0.54 | 0.4304 | 14477 | 0.48101284 | CS |
4 | -0.1349 | -21.9349593496 | 0.615 | 0.672 | 0.37 | 26265 | 0.48115405 | CS |
12 | -0.6099 | -55.9541284404 | 1.09 | 1.12 | 0.37 | 44010 | 0.71776093 | CS |
26 | -0.6099 | -55.9541284404 | 1.09 | 1.12 | 0.37 | 44010 | 0.71776093 | CS |
52 | -0.6099 | -55.9541284404 | 1.09 | 1.12 | 0.37 | 44010 | 0.71776093 | CS |
156 | -0.6099 | -55.9541284404 | 1.09 | 1.12 | 0.37 | 44010 | 0.71776093 | CS |
260 | -0.6099 | -55.9541284404 | 1.09 | 1.12 | 0.37 | 44010 | 0.71776093 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions